If your baby is currently sick with floppiness, weak crying, poor feeding, drooling, or breathing problems — and was fed Nara Organics Powdered Infant Formula — seek emergency care immediately. Tell the medical team about the formula and the recall.
On June 12, 2026, Nara Organics voluntarily recalled all lots of its powdered infant formula after the FDA and CDC linked three hospitalized infant botulism cases — in California, Washington, and Pennsylvania — to consumption of the product. The infants were treated with BabyBIG (Botulism Immune Globulin Intravenous-Human) and none have died. The product has not yet tested positive for Clostridium botulinum, but the recall covers all currently distributed lots out of an abundance of caution.
For families of infants affected by the recall, two questions become important. The first is medical: what should parents watch for, and what care does a baby with suspected infant botulism need? The second is legal: when a hospital or pediatrician fails to recognize infant botulism on time, what does that mean for a possible malpractice case?
What Infant Botulism Is
Infant botulism is a rare but serious paralytic illness caused by Clostridium botulinum spores germinating in a baby's gut and producing a neurotoxin that blocks signals to muscles. The condition is most common in infants under one year of age — particularly between 2 and 8 months — because their immature gut bacteria allow the spores to grow. Older children and adults can ingest the same spores without becoming ill.
Approximately 100-150 cases of infant botulism are diagnosed each year in the United States. Most cases recover fully with treatment. Untreated or delayed-treatment cases can progress to respiratory failure and death.
The Symptoms Parents and Clinicians Should Recognize
Infant botulism progresses over hours to days. The classic symptoms in order of typical appearance:
- Constipation — often the earliest sign, sometimes preceding other symptoms by days. A baby who was previously regular suddenly stops having bowel movements.
- Decreased feeding, poor suck — the muscles involved in feeding lose strength.
- Weak cry — the cry becomes faint or hoarse.
- Loss of head control, generalized floppiness ("floppy baby") — muscle weakness becomes generalized.
- Drooping eyelids (ptosis), decreased facial expression — the cranial nerves are affected.
- Drooling — loss of muscle control in the mouth.
- Breathing problems — the most dangerous progression; respiratory muscle weakness can require ventilator support.
The Treatment Standard
The standard treatment for infant botulism is BabyBIG (Botulism Immune Globulin Intravenous-Human), distributed by the California Department of Public Health Infant Botulism Treatment and Prevention Program. BabyBIG is FDA-approved and has been shown to significantly reduce hospital stay length, ICU stay length, and mechanical ventilation requirements.
Best outcomes require early diagnosis and prompt BabyBIG administration. Delays in recognition correlate with longer hospital stays, higher rates of mechanical ventilation, and more frequent complications.
When Missed Diagnosis Becomes Malpractice
Infant botulism is rare enough that not every emergency department physician or pediatrician has encountered it. But the standard of care requires recognition when the clinical picture is consistent — particularly now that the June 2026 Nara recall has put infant botulism in the news and on clinical advisories from the FDA, CDC, and state health departments.
Common patterns of failure in infant botulism cases:
The "feeding problem" misdiagnosis
The baby presents with poor feeding and decreased activity. The clinician assumes "feeding intolerance" or "fussiness" without considering neurologic causes. The baby is sent home and returns hours or days later in respiratory failure.
The "sepsis" workup that misses botulism
The baby is admitted for "rule out sepsis" with the floppy baby presentation. Cultures are negative; antibiotics are started anyway. Botulism is not on the differential. The baby's condition progresses while the team works through alternative diagnoses.
The constipation dismissal
Parents bring up constipation. The clinician treats it symptomatically without exploring the rest of the clinical picture or considering botulism. The baby returns days later with weakness.
The delay in BabyBIG administration
The diagnosis is made but BabyBIG is not requested or administered promptly. Each day of delay is associated with worse outcomes. Hospitals are expected to know how to access BabyBIG through the California program.
The food-exposure history not taken
Standard pediatric history-taking should ask about honey exposure and, after the Nara recall, infant formula brand. A botulism case where the formula exposure history was not asked is a case where critical diagnostic information was missed.
Why timing matters legally. Damages in infant botulism cases depend heavily on whether the baby received early treatment and recovered, or whether delays produced longer ICU stays, mechanical ventilation, hypoxic injury, or death. The interval between when the diagnosis should have been made and when treatment actually began is the central legal question.
What Parents Should Do Now
- If your baby received Nara Organics Powdered Infant Formula: Stop using it. Save the container if possible (the lot number matters).
- Watch for symptoms. Constipation, weak cry, floppy movements, poor feeding, drooling, drooping eyelids, breathing problems.
- If any symptoms appear: Go to the emergency department immediately. Tell the medical team the baby was fed Nara formula and that the product was recalled for potential C. botulinum contamination.
- Preserve documentation. The container, the receipts, all hospital records, photos or video of the baby's symptoms if possible.
- Pursue the refund. Nara is refunding through nara.com and Target stores.
If Your Baby Was Hurt by Delayed Diagnosis
If your baby was sick with infant botulism and the diagnosis was delayed, missed, or mishandled — particularly if the delay resulted in mechanical ventilation, ICU stay extension, hypoxic injury, or death — a free case review can identify whether the case fits the pattern of a viable malpractice claim. Time matters; medical records, hospital quality data, and witness recall are all freshest in the first weeks after the event.
- Read about Group B strep newborn infection cases (a related but distinct pattern): Group B Strep Negligence.
- Read about HIE: HIE and Birth Asphyxia.
- Understand birth-injury statute of limitations: Birth Injury Statute of Limitations.
- Understand life care planning: What Is a Life Care Plan?
Free case review. No fees unless we recover compensation for you.
Sources
- U.S. Food & Drug Administration — "Nara Organics Recalls All Lots of Nara Infant Formula Because of Possible Health Risk." fda.gov
- U.S. Food & Drug Administration — "Outbreak Investigation of Infant Botulism: Powdered Infant Formula (June 2026)." fda.gov
- Centers for Disease Control and Prevention — "Infant Botulism Outbreak Linked to Powdered Infant Formula, June 2026." cdc.gov
- California Department of Public Health — Infant Botulism Treatment and Prevention Program (BabyBIG). infantbotulism.org
- American Academy of Pediatrics — Infant botulism clinical guidance. aap.org